Lung Cancer News

David Carbone, MD, PhD, received International Association for the Study of Lung Cancer’s Paul A. Bunn Jr. Scientific Award.

Treatment at high-volume radiation therapy facilities correlated with improved survival among select patients with common malignancies, according to study results published in Cancer.

Reducing excess body fat and adjusting factors of metabolic syndrome can greatly lower the risk for lung disease among World Trade Center first responders, according to data in the American Journal of Respiratory and Critical Care Medicine.

The combination of tumor-infiltrating lymphocytes and nivolumab induced tumor regression among more than two-thirds of patients with stage IV non-small cell lung cancer, according to results of a phase 1 study published in Nature Medicine.

Exposure to the colorless, odorless gas called radon is the second leading cause of lung cancer in the U.S. and the leading cause of lung cancer among nonsmokers, according to the American Cancer Society.

A deep learning score accurately predicted PD-L1 expression among a cohort of patients with non-small cell lung cancer who underwent PET/CT scans, according to study findings published in Journal for ImmunoTherapy of Cancer.

Perioperative combination therapy using a long-acting muscarinic antagonist and long-acting beta agonist may be an optimal treatment for patients with lung cancer and COPD undergoing cancer for lung surgery, researchers reported.

A phase 3 trial of cemiplimab-rwlc plus chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer has been stopped early after achieving its primary endpoint of improved OS, according to the agent’s manufacturer.

The addition of plinabulin to docetaxel during second- or third-line treatment significantly extended OS for patients with EGFR wild-type non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

The FDA granted priority review to atezolizumab as adjuvant treatment for certain people with non-small cell lung cancer.